Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totaling 69,756 shares, a drop of 48.9% from the September 30th total of 136,510 shares. Based on an average daily trading volume, of 111,519 shares, the short-interest ratio is presently 0.6 days.
Wall Street Analysts Forecast Growth
SMMNY has been the topic of several research reports. Citigroup reaffirmed a “buy” rating on shares of Siemens Healthineers in a report on Tuesday, October 13th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Zacks Research cut Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Thursday, October 1st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Analysis on Siemens Healthineers
Siemens Healthineers Stock Down 0.7%
Shares of SMMNY stock opened at $23.81 on Friday. The stock’s 50-day moving average is $22.43 and its two-hundred day moving average is $22.00. Siemens Healthineers has a fifty-two week low of $19.20 and a fifty-two week high of $28.43.
About Siemens Healthineers
Siemens Healthineers AG is a global medical technology company headquartered in Erlangen, Germany. The company develops, manufactures and provides products, services and digital solutions that support the prevention, diagnosis and treatment of disease. Siemens Healthineers operates as a separately managed company within the broader Siemens group and has served healthcare providers in markets around the world.
Its portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, X-ray and molecular imaging equipment, as well as ultrasound systems.
Further Reading
- Five stocks we like better than Siemens Healthineers
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
